LENZ Therapeutics Launches VIZZ Telehealth Prescribing Option for the Treatment of Presbyopia

Published on July 8, 2026
SAN DIEGO—LENZ Therapeutics, Inc. (Nasdaq: LENZ), a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, an aceclidine-based eye drop for the treatment of presbyopia, has announced that VIZZ is now available through a new telehealth platform, providing the convenience of an integrated online evaluation by independent licensed eyecare providers, e-pharmacy prescription fulfillment and home delivery. By visiting the integrated telehealth platform, patients can fill out and submit an online medical history form, allowing an independent network of licensed ECPs to connect with patients and evaluate their eligibility for telehealth services. Prescriptions will be automatically routed and fulfilled by LENZ’s e-pharmacy partner, the announcement said.
Continue reading on website
Other news

Jobson Research Releases Census ProCount 2026, a Database of Optical Locations

July 8, 2026
NEWARK, N.J.—Jobson Research has issued the 2026 iteration of its Census ProCount, a database of approximately 38,000 optical locations in the U.S. The database features independents and chains with up to 50 locations that are open and operating in 2026. The Census data contains the practice/company name, address, phone, county, website, estimated annual retail sales, square footage, newly establi

RestoringVision Partners With Government of Saint Lucia to Broaden Access to Vision Care

July 8, 2026
SAINT LUCIA—RestoringVision announced it has signed a memorandum of understanding (MoU) with the government of Saint Lucia to expand access to essential vision care services, marking a significant step toward improving eye health and quality of life across the island. The agreement, signed on June 18, 2026, supports a Prime Ministerial Vision Initiative that will integrate presbyopia screening and